Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Cytokine release syndrome? 442 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 442 reports of Cytokine release syndrome have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.

442
Reports of Cytokine release syndrome with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
48
Deaths
340
Hospitalizations

How Dangerous Is Cytokine release syndrome From LENALIDOMIDE?

Of the 442 reports, 48 (10.9%) resulted in death, 340 (76.9%) required hospitalization, and 30 (6.8%) were considered life-threatening.

Is Cytokine release syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 442 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Cytokine release syndrome?

AXICABTAGENE CILOLEUCEL (4,140) CYCLOPHOSPHAMIDE (2,263) TISAGENLECLEUCEL (1,660) FLUDARABINE (1,458) RITUXIMAB (1,404) BLINATUMOMAB (952) DEXAMETHASONE (853) DOXORUBICIN (850) BREXUCABTAGENE AUTOLEUCEL (827) VINCRISTINE (771)

Which LENALIDOMIDE Alternatives Have Lower Cytokine release syndrome Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Cytokine release syndrome Reports All Drugs Causing Cytokine release syndrome LENALIDOMIDE Demographics